GSK
$36.64
Revenue | $8012Mn |
Net Profits | $-58Mn |
Net Profit Margins | -0.72% |
PE Ratio | 23.54 |
Gsk Plc-spon Adr.’s revenue fell -0.5% since last year same period to $8012Mn in the Q3 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 1.62% jump in its revenue since last 3-months.
Gsk Plc-spon Adr.’s net profit fell -116.57% since last year same period to $-58Mn in the Q3 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -104.94% fall in its net profits since last 3-months.
Gsk Plc-spon Adr.’s net profit margin fell -116.65% since last year same period to -0.72% in the Q3 2024. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -104.87% fall in its net profit margins since last 3-months.
Gsk Plc-spon Adr.’s price-to-earnings ratio after this Q3 2024 earnings stands at 23.54.
EPS Estimate Current Quarter | 0.49 |
EPS Estimate Current Year | 0.49 |
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 0.49 - a -60.36% fall from last quarter’s estimates.
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 0.49.
Earning Per Share (EPS) | 0.58 |
Dividend Per Share (DPS) | 0.39 |
Gsk Plc-spon Adr.’s earning per share (EPS) fell -19.56% since last year same period to 0.58 in the Q4 2024. This indicates that the Gsk Plc-spon Adr. has generated -19.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Gsk Plc-spon Adr. declared 0.39 dividend per share during the earnings announcement for Q4 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | 1.23 | 1.29 | 4.88% |
2024-06-30 | 0.99 | 1.1 | 11.11% |
2025-02-05 | 0.49 | 0.58 | 18.79% |
2024-03-31 | 0.91 | 1.09 | 19.78% |